Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06783751 · ClinicalTrials.gov registry record · NA
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
A NA study of Obesity and Gastroesophageal Reflux Disease, sponsored by University of California, Irvine.
- Recruiting
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 2
- Study locations
NCT06783751: Recruiting NA study of Obesity and Gastroesophageal Reflux Disease, sponsored by University of California, Irvine.
NCT06783751 is a NA study of Obesity and Gastroesophageal Reflux Disease that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 44 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06783751, a NA study of Obesity and Gastroesophageal Reflux Disease, is actively recruiting participants, sponsored by University of California, Irvine.
- RECRUITING
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a two-site randomized clinical trial aiming to test whether a modified investigational bariatric surgical procedure can improve gastroesophageal reflux disease (GERD) after sleeve gastrectomy.
Primary Outcome
Change in %AET in percentage points at Month 6-9 relative to pre-surgery %AET assessed with the Bravo pH test
Conditions Studied
Interventions
- PROCEDURE Modified Vertical Sleeve Gastrectomy (mVSG)
- PROCEDURE Conventional Vertical Sleeve Gastrectomy (cVSG)
Study Locations (2)
California
- University of California, Irvine - Orange
- University of California, San Diego - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2025-03-21 |
| Est. Completion | 2027-07-31 |
| Phase | NA |
What NCT06783751 shows while recruiting
NCT06783751 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (95% lower).
The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Modified Vertical Sleeve Gastrectomy (mVSG) is the first listed.
NCT06783751 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06783751 about?
NCT06783751 is a clinical study titled "Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)". This is a two-site randomized clinical trial aiming to test whether a modified investigational bariatric surgical procedure can improve gastroesophageal reflux disease (GERD) after sleeve gastrectomy.
What is the current status of trial NCT06783751?
This trial is currently recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2025-03-21. Estimated completion is 2027-07-31.
What conditions does trial NCT06783751 study?
This clinical trial studies the following conditions: Obesity, Gastroesophageal Reflux Disease, Bariatric Surgery, Sleeve Gastrectomy.
What interventions are being tested in trial NCT06783751?
The interventions under investigation include: Modified Vertical Sleeve Gastrectomy (mVSG) (PROCEDURE), Conventional Vertical Sleeve Gastrectomy (cVSG) (PROCEDURE).
Who is sponsoring clinical trial NCT06783751?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06783751 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06783751's enrollment target sits among peer trials
44 760th of 1053 higher than 288 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI